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and target the ULS patients most likely to benefit from BoNT-A treatment.
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A study was conducted to evaluate the effect of treatment on triceps surae
spasticity in hemiparetic patients using a quantitative and reproducible
parameter: the anterior-posterior path length of the center of pressure (COP).
The F-Scan system used the embedded footings to analyze the path of the COP
and the plantar pressure during walking.
COP parameters have a good repeatability in hemiparetic patients [1].
The population consisted of 10 hemiparetic patients (six left, four right), with
disturbing spasticity of the triceps surae during ambulation, able to walk alone
with or without technical assistance (FAC functional scale between 3 and 5).
After clinical examination, walking study was achieved at own speed (with or
without technical assistance), before and after an anesthesic block of the
posterior tibial nerve. The session comprised of baropodometric, spatiotempo-
ral recordings, and a videographic survey.
The main variable analyzed was the change of anterior-posterior path length of
the COP (AP) in hemiparetic side after completion of the nerve block.
According to literature, a significant decrease in the AP in paretic side compared
to the non-paretic side was found before the nerve block [2]. AP increased
significantly after completion of the nerve block (112 vs 99 mm, P = 0.03).
In conclusion, we find a significant variation of a quantitative variable of gait in
hemiparetic patients after abolition of spasticity.
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Objective.– To examine differences in complication rates between children and
adults treated by intrathecal baclofen.
Material and method.– Retrospective chart review of 73 patients (adults and
children; 88 pumps) with a diagnosis of severe spasticity requiring intrathecal
baclofen therapy.
Results.– Complication rates by category were as follows: related to human
error: 8%, related to baclofen: 11%, related to surgery: 19% and related to the
implantable device: 27%. Complications were more frequent in adults than in
children, except for complications related to surgery. The complication raterelated to the implantable device was higher in ambulatory patients. The
complication rates related to surgery and the implantable device decreased
during the course of the study.
Conclusions.– The overall complication rate observed in our series is
comparable to that reported in the literature and, in contrast with the literature,
was not higher in children than in adults. Only complications related to the
surgical procedure were slightly more common in children. Baclofen pump
implantation in children is therefore a safe procedure.
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Introduction.– The anesthetic blocks are currently in the arsenal of diagnostic
and therapeutic motor disorders associated with spasticity.
The aim of our study is to clarify the interest of the anesthetic block in patient
assessment spastic.
Patients and methods.– Twenty patients hospitalized in the physical medicine
and functional rehabilitation were selected over a period of 2 years (since
January 2010) and who received anesthetic block during their hospitalization.
These were patients aged between 13 and 72 years (mean age 43 years) with
vascular hemiplegia in 12 cases (60%), cerebral palsy in three cases (15%),
spinal cord injury in three cases (15%), head trauma in 1 case (5%) and a
hereditary disease in one case (5%).
The anesthetic blocks were performed by specific needles and a pacemaker,
respecting the location techniques. The anaesthetic used was mainly 2% non-
adrenalized etidocaine (Xylocaïne1) An analytical assessment of spasticity by
the Ashworth score and functional walking was performed for each patient.
Results.– Twenty anesthetic blocks were performed. The injected sites were
dominated by the soleus nerve (48%), the median nerve (33%) and the posterior
tibial nerve (11%).
We noted an Ashworth score gain of about 1 to 2 points, a gain of 138 joint and
an average improvement of gait in 11 patients (64%).
Fifteen patients (75%) benefited from an injection of botulinum toxin and one
patient was operated (neurotomy).
Conclusion.– The anesthetic blocks currently represent a simple and effective
approach with a dual interest in diagnosis and prognosis.
They are shown to reproduce the transient effect expected a more sustainable
and therefore more costly by providing an effective local treatment of spasticity.
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Introduction.– Primary and secondary dystonia with truncal dystonia are often
associated with spinal involvement as low-back pain. Interest of botulinum
toxin is well described in literature for cervical dystonia but less for truncal
dystonia. We report the case of a patient who received local botulinum toxin
Spasticite´ (III) / Revue d’E´pide´miologie et dee340injections into the lumbar paraspinal muscles and we review the relevant
literature.
Case report.– A 27-year-old patient, with PKAN heredodegenerative dystonia,
has truncal dystonia symptomatology. Suddenly, she complained of low-back
pain evaluated at 10/10 on a verbal scale. Low-back pain is induced by repetitive
dystonic movements with upper limbs anterior elevation, spinal and hip
extension (opisthotonos). Radiographs showed a L3 bilateral spondylolysis not
shown in the previous radiographs. A classical corset immobilization isn’t
possible because of movement disorders. A first botulinum toxin injection is
performed (150 UI Botox1) in lumbar paraspinal muscles for pain relief.
Anterior head of deltoideus and gluteus maximus are also injected (for a total
dose of 400 UI Botox1 each session) to break the extension scheme. Four weeks
after injections, the pain is evaluated at 5/10 and movement disorders were less
frequent. Thanks to the adapted wheelchair and the posterior articulars
infiltration bilaterally (125 mg of hydrocortancyl), the patient is totally relieved.
Because of pain recurrence, toxin injections are effectively renewed each 3
months.
Discussion.– The increase of spondylolysis frequency is shown in CP patients
[1], one of the most frequent pathology with dystonia. The effectiveness of
botulinum toxin injections in spinal muscles to decrease contractions is hard to
prove but some articles agree with a decrease of disordered movements and pain
[2].
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We are reporting a case of a pneumothorax after BoNT-A injection.
A 58-year-old patient with right spastic proportional hemiplegia due to a
frontal meningioma surgery 36 years before required regular BoNT-A
injections. The muscles (subscapularis, anterior and posterior way, and
pectoralis major, two anterior injection sights) were injected with the help of
electrostimulation detection. During the 6th session, the subscapularis was
detected with difficulty. Two hours after the injection the patient presented
acute dyspnea. A pneumothorax was diagnosed and drained; the patient was
hospitalized in intensive care for 5 days. A relation between the injection and
the pneumothorax was then established. There were no after effects of this
episode.
This is the first described case of pneumothorax after BoNT-A injection. The
probable cause was the detection of the subscapularis and not the pectoralis
major who is superficial and easily spotted.
Similar cases were described during electromyographic exams of the muscles
teres major and pectoralis major but never for the subscapularis [1].
This case reminds of the necessity of a technical aid for the detection of the
muscles to be injected, as well as the risks taken while trying to detect thoracic
muscles.
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Introduction.– Botulinum toxin is an effective treatment for neurogenic or
idiopathic detrusor overactivity refractory to antimuscarinics. Nevertheless, it
can lead to locoregional and sometimes systemic complications like botulism-
like syndrome.
Observation.– A 24-year-old woman, quadriplegic Cervical 7 ASIA C, spastic
post-traumatic with detrusor overactivity at urodynamic assessment, was
effectively treated for a year by antimuscarinics and intradetrusor botulinum
toxin injections. Ten days after the last injection (Botox 300 UI), the patient
complained of generalized muscle weakness, an inability to manipulate the
steering wheel of her car and to transfer. The physical examination revealed an
increase in the deficit of the triceps (MRC scale 2 vs 3+ initially), and a loss of
67 and 72% of strength in the isometric assessment of right and left deltoids
respectively. The vital capacity was 2.07 L vs 2.36 L initially. The
neuromuscular jitter of the orbicularis oculi was impaired with 22.7% of
abnormal fibers and a mean jitter of 27.45 msec. Differential diagnoses were
excluded with anti-Musk and anti-Ach R negative, a spinal MRI showing the
absence of syringomyelia and compressive disc hernia, and the diagnosis of
botulism-like syndrome was made. The patient had a clinical and electro-
physiological follow-up, with a normalization of muscle power in a year and
slow improvement of neuromuscular jitter.
Discussion.– Several cases of generalized muscle weakness after intradetrusor
botulinum toxin injections have been described, with poorly understood
pathophysiological mechanisms. The interest of this observation is the one-year
follow-up with electrophysiological measures, muscle power evaluation and
occupational therapy evaluation of prehension. General complications of
botulinum toxin injections for detrusor overactivity require regular clinical and
electrophysiological monitoring. Patients should be informed of this potential
risk.
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Introduction.– The stiff-knee is a lack of shortening of the lower limb during
walking secondary to a defect of knee flexion during the swing phase. This is a
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